help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Junier, M. P.
Right arrow Articles by Ojeda, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Junier, M. P.
Right arrow Articles by Ojeda, S. R.

Endocrinology, Vol 126, 1534-1540, Copyright © 1990 by Endocrine Society


ARTICLES

Epoxygenase products of arachidonic acid are endogenous constituents of the hypothalamus involved in D2 receptor-mediated, dopamine-induced release of somatostatin

MP Junier, F Dray, I Blair, J Capdevila, E Dishman, JR Falck and SR Ojeda
Division of Neuroscience, Oregon Regional Primate Research Center, Beaverton 97006.

The epoxyeicosatrienoic acids (EETs) were discovered as products of a cyclooxygenase/lipoxygenase-independent, cytochrome P-450 catalyzed metabolism of arachidonic acid (AA) termed the "epoxygenase" pathway. The rat hypothalamus is able to synthesize EETs from exogenous AA, and 5,6-EET has been found to release the neuropeptide somatostatin (SRIF) from hypothalamic nerve terminals of the median eminence (ME). In the present study, hypothalami from male rats were examined for the presence of endogenous EETs, using chemical, chromatographic, and mass spectral analysis procedures. The samples were initially separated in a C18 Sepralyte column, fractionated on TLC plates, and purified by reverse phase HPLC. Thereafter, they were esterified (pentafluorobenzyl esters) and subjected to negative ion chemical ionization/gas chromatography (GC)/mass spectral (MS) analysis. The GC retention time and the MS fragmentation patterns revealed the presence of a mixture of 8,9-, 11,12- and 14,15-EETs; instability of 5,6-EET during the isolation protocol precluded its identification. Total hypothalamic EET concentration was estimated to be 120 ng/g wet tissue. The 8,9- regiosomer released SRIF from ME nerve terminals with an ED50 of 5 x 10(-12) M; Dopamine (DA) and the D2 receptor agonist PPHT, but not the D1 receptor agonist SKF-38393, induced SRIF release from the ME. This effect was blocked by clotrimazole and ketoconazole, two inhibitors of microsomal cytochrome P-450 function and AA epoxygenase in particular. In contrast, the inhibitors failed to affect the increase in SRIF release induced by 8,9-EET. These results indicate that: 1) in addition to cyclooxygenase and lipoxygenase products, epoxygenase metabolites of AA are endogenous compounds of the hypothalamus, and 2) EETs may mediate the increase in SRIF release from hypothalamic neurons induced by the interaction of DA with D2 receptors.


This article has been cited by other articles:


Home page
EndocrinologyHome page
D. X. Zhang, K. M. Gauthier, J. R. Falck, A. Siddam, and W. B. Campbell
Steroid-Producing Cells Regulate Arterial Tone of Adrenal Cortical Arteries
Endocrinology, August 1, 2007; 148(8): 3569 - 3576.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. A. Spector and A. W. Norris
Action of epoxyeicosatrienoic acids on cellular function
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. Yang, K. M. Gauthier, L. M. Reddy, B. Sangras, K. K. Sharma, K. Nithipatikom, J. R. Falck, and W. B. Campbell
Stable 5,6-Epoxyeicosatrienoic Acid Analog Relaxes Coronary Arteries Through Potassium Channel Activation
Hypertension, April 1, 2005; 45(4): 681 - 686.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Jiang, J. C. McGiff, J. Quilley, D. Sacerdoti, L. M. Reddy, J. R. Falck, F. Zhang, K. M. Lerea, and P. Y-K Wong
Identification of 5,6-trans-Epoxyeicosatrienoic Acid in the Phospholipids of Red Blood Cells
J. Biol. Chem., August 27, 2004; 279(35): 36412 - 36418.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S.-G. Ren, S. Kim, J. Taylor, J. Dong, J.-P. Moreau, M. D. Culler, and S. Melmed
Suppression of Rat and Human Growth Hormone and Prolactin Secretion by a Novel Somatostatin/Dopaminergic Chimeric Ligand
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5414 - 5421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. Oleksiak, S. Wu, C. Parker, S. I. Karchner, J. J. Stegeman, and D. C. Zeldin
Identification, Functional Characterization, and Regulation of a New Cytochrome P450 Subfamily, the CYP2Ns
J. Biol. Chem., January 28, 2000; 275(4): 2312 - 2321.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. J. Alkayed, J. Narayanan, D. Gebremedhin, M. Medhora, R. J. Roman, and D. R. Harder
Molecular Characterization of an Arachidonic Acid Epoxygenase in Rat Brain Astrocytes
Stroke, May 1, 1996; 27(5): 971 - 979.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
W. Qu, J. A. Bradbury, C.-C. Tsao, R. Maronpot, G. J. Harry, C. E. Parker, L. S. Davis, M. D. Breyer, M. P. Waalkes, J. R. Falck, et al.
Cytochrome P450 CYP2J9, a New Mouse Arachidonic Acid omega -1 Hydroxylase Predominantly Expressed in Brain
J. Biol. Chem., June 29, 2001; 276(27): 25467 - 25479.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society